EUVIMEDEUVIMED entdecken
Multizentrische Studie

Multicentre evaluation of teicoplanin prescribing and monitoring in the UK and Ireland: the TUcK–SHOP study

Stephen Hughes iD, Jamie Cheong, Jonathan Snape, Shilpa Jethwa, Song Heng Ng, Rajeni Thangarajah, Tanya Escayo, Ben Mcintyre, Sue Wei Chong, Andrew Stone, Rhys Oakley, Kevin Frost iD und 13 weitere

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkag038 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Stephen Hughes und 24 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Chelsea and Westminster NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Teicoplanin, Anti-Bacterial Agents, Drug Monitoring. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Teicoplanin exhibits complex pharmacokinetics with substantial inter-patient variability. Therapeutic drug monitoring (TDM) is recommended to ensure adequate exposure, yet contemporary data on real-world prescribing practices are scarce. We evaluated current teicoplanin dosing and monitoring practices across UK and Irish hospitals.

Methods

We conducted a multicentre, retrospective cohort study (Teicoplanin in UK: Study of Hospital Practice; TUcK–SHOP) across 21 hospitals. Adults receiving ≥5 days of intravenous/intramuscular teicoplanin with at least one TDM sample were included. Primary outcome was adherence to local or national dosing guidelines. Secondary outcomes included initial trough level attainment (≥20 mg/L) and laboratory-confirmed toxicity. Multivariable linear regression identified predictors of first trough concentrations.

Results

A total of 391 patients met inclusion criteria (median age 69 years; 57.5% male). Guideline adherence was 66% overall but varied widely between sites (5%–100%). Most patients received three-dose loading (61.3%) with median maintenance dosing of 10.6 mg/kg daily (IQR 7.3–12.1). Median first trough level was 24.6 mg/L (IQR 17.9–33.2); only 40.8% of patients on 6 mg/kg maintenance achieved ≥20 mg/L versus 86.6% on 12 mg/kg (P < 0.001). Independent predictors of higher trough levels included lower creatinine clearance, longer time to TDM sampling, higher loading and maintenance doses, and greater body weight (adjusted R2 = 0.26, P < 0.001). Dose adjustments were required in 30% of patients.

Conclusions

Teicoplanin prescribing demonstrates significant variation across UK and Irish hospitals. Higher maintenance dosing (10–12 mg/kg) predicts therapeutic target attainment. These real-world data support the need for standardized dosing protocols to optimize teicoplanin therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TeicoplaninAnti-Bacterial AgentsDrug MonitoringHumansIrelandUnited KingdomFemaleMaleRetrospective StudiesAgedMiddle AgedGuideline AdherenceAged, 80 and over

Substanzen

TeicoplaninAnti-Bacterial Agents

Autor:innen und Institutionen

  • Pharmacy Department, Chelsea and Westminster NHS Foundation Trust, London, UK.
  • Pharmacy Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Pharmacy Department, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
  • Pharmacy Department, Luton and Dunstable University Hospital NHS Foundation Trust, Luton, UK.
  • Pharmacy Department, Lincolnshire Community and Hospitals NHS Group, UK.
  • Pharmacy Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

ORCID-Profile: Stephen Hughes, Kevin Frost, Cassandra Watson, Claire Brandish, Nirlep Agravedi, Ryan Hamilton

Zitieren

APA

Hughes, S., Cheong, J., Snape, J., Jethwa, S., Ng, S. H., Thangarajah, R., Escayo, T., Mcintyre, B., Chong, S. W., Stone, A., Oakley, R., Frost, K., Watson, C., Brandish, C., Martin, D., Lewis, N., Liu, A., Patel, R., Ahmad, D., …, & Hamilton, R. (2026). Multicentre evaluation of teicoplanin prescribing and monitoring in the UK and Ireland: the TUcK–SHOP study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag038

Vancouver

Hughes S, Cheong J, Snape J, Jethwa S, Ng SH, Thangarajah R, et al. Multicentre evaluation of teicoplanin prescribing and monitoring in the UK and Ireland: the TUcK–SHOP study. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag038

BibTeX
@article{Hughes2026,
  author = {Hughes, Stephen and Cheong, Jamie and Snape, Jonathan and Jethwa, Shilpa and Ng, Song Heng and Thangarajah, Rajeni and Escayo, Tanya and Mcintyre, Ben and Chong, Sue Wei and Stone, Andrew and Oakley, Rhys and Frost, Kevin and Watson, Cassandra and Brandish, Claire and Martin, Donna and Lewis, Nicki and Liu, Alice and Patel, Rakhee and Ahmad, Duaa and Patel, Ayesha and Agravedi, Nirlep and Hussain, Nauman and May, Sarah and Newby, Kelly and Hamilton, Ryan},
  title = {Multicentre evaluation of teicoplanin prescribing and monitoring in the UK and Ireland: the TUcK–SHOP study},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkag038}
}
Kostenlos starten →